 | • レポートコード：GIR201114399 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、第IX因子欠乏症治療の世界市場を調査対象にし、第IX因子欠乏症治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（血友病B、血友病B阻害剤）、用途別分析（病院、診療所、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Pfizer、Biogen、Takeda、Novo Nordisk、CSL Behring ・企業別売上、市場シェア ・第IX因子欠乏症治療の地域別市場分析 ・第IX因子欠乏症治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・第IX因子欠乏症治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・第IX因子欠乏症治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・第IX因子欠乏症治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・第IX因子欠乏症治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・第IX因子欠乏症治療の種類別市場規模2015-2020：血友病B、血友病B阻害剤 ・第IX因子欠乏症治療の用途別市場規模2015-2020：病院、診療所、その他 ・第IX因子欠乏症治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Factor IX Deficiency Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Factor IX Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Factor IX Deficiency Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Factor IX Deficiency Treatment market has been segmented into:
Hemophilia B
Hemophilia B Inhibitors
By Application, Factor IX Deficiency Treatment has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Factor IX Deficiency Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Factor IX Deficiency Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Factor IX Deficiency Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Factor IX Deficiency Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Factor IX Deficiency Treatment Market Share Analysis
Factor IX Deficiency Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Factor IX Deficiency Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Factor IX Deficiency Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Factor IX Deficiency Treatment are:
Pfizer
Biogen
Takeda
Novo Nordisk
CSL Behring
Table of Contents
1 Factor IX Deficiency Treatment Market Overview
1.1 Product Overview and Scope of Factor IX Deficiency Treatment
1.2 Classification of Factor IX Deficiency Treatment by Type
1.2.1 Global Factor IX Deficiency Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Factor IX Deficiency Treatment Revenue Market Share by Type in 2019
1.2.3 Hemophilia B
1.2.4 Hemophilia B Inhibitors
1.3 Global Factor IX Deficiency Treatment Market by Application
1.3.1 Overview: Global Factor IX Deficiency Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Factor IX Deficiency Treatment Market by Regions
1.4.1 Global Factor IX Deficiency Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Factor IX Deficiency Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biogen SWOT Analysis
2.2.4 Biogen Product and Services
2.2.5 Biogen Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novo Nordisk SWOT Analysis
2.4.4 Novo Nordisk Product and Services
2.4.5 Novo Nordisk Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 CSL Behring
2.5.1 CSL Behring Details
2.5.2 CSL Behring Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CSL Behring SWOT Analysis
2.5.4 CSL Behring Product and Services
2.5.5 CSL Behring Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Factor IX Deficiency Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Factor IX Deficiency Treatment Players Market Share
3.2.2 Top 10 Factor IX Deficiency Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Factor IX Deficiency Treatment Revenue and Market Share by Regions
4.2 North America Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
5 North America Factor IX Deficiency Treatment Revenue by Countries
5.1 North America Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
5.2 USA Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6 Europe Factor IX Deficiency Treatment Revenue by Countries
6.1 Europe Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
6.2 Germany Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.4 France Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Factor IX Deficiency Treatment Revenue by Countries
7.1 Asia-Pacific Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
7.2 China Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.5 India Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
8 South America Factor IX Deficiency Treatment Revenue by Countries
8.1 South America Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
8.2 Brazil Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Factor IX Deficiency Treatment by Countries
9.1 Middle East & Africa Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Factor IX Deficiency Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Factor IX Deficiency Treatment Market Forecast by Type (2019-2024)
10.3 Hemophilia B Revenue Growth Rate (2015-2025)
10.4 Hemophilia B Inhibitors Revenue Growth Rate (2015-2025)
11 Global Factor IX Deficiency Treatment Market Segment by Application
11.1 Global Factor IX Deficiency Treatment Revenue Market Share by Application (2015-2020)
11.2 Factor IX Deficiency Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Factor IX Deficiency Treatment Market Size Forecast (2021-2025)
12.1 Global Factor IX Deficiency Treatment Market Size Forecast (2021-2025)
12.2 Global Factor IX Deficiency Treatment Market Forecast by Regions (2021-2025)
12.3 North America Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
12.6 South America Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Factor IX Deficiency Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Factor IX Deficiency Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Factor IX Deficiency Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Factor IX Deficiency Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Factor IX Deficiency Treatment Major Business
Table 7. Pfizer Factor IX Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Factor IX Deficiency Treatment Product and Solutions
Table 10. Pfizer Factor IX Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Biogen Corporate Information, Location and Competitors
Table 12. Biogen Factor IX Deficiency Treatment Major Business
Table 13. Biogen Factor IX Deficiency Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Biogen SWOT Analysis
Table 15. Biogen Factor IX Deficiency Treatment Product and Solutions
Table 16. Biogen Factor IX Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Takeda Corporate Information, Location and Competitors
Table 18. Takeda Factor IX Deficiency Treatment Major Business
Table 19. Takeda Factor IX Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Takeda SWOT Analysis
Table 21. Takeda Factor IX Deficiency Treatment Product and Solutions
Table 22. Takeda Factor IX Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novo Nordisk Corporate Information, Location and Competitors
Table 24. Novo Nordisk Factor IX Deficiency Treatment Major Business
Table 25. Novo Nordisk Factor IX Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Novo Nordisk SWOT Analysis
Table 27. Novo Nordisk Factor IX Deficiency Treatment Product and Solutions
Table 28. Novo Nordisk Factor IX Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. CSL Behring Corporate Information, Location and Competitors
Table 30. CSL Behring Factor IX Deficiency Treatment Major Business
Table 31. CSL Behring Factor IX Deficiency Treatment Total Revenue (USD Million) (2017-2018)
Table 32. CSL Behring SWOT Analysis
Table 33. CSL Behring Factor IX Deficiency Treatment Product and Solutions
Table 34. CSL Behring Factor IX Deficiency Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Factor IX Deficiency Treatment Revenue (Million USD) by Players (2015-2020)
Table 36. Global Factor IX Deficiency Treatment Revenue Share by Players (2015-2020)
Table 37. Global Factor IX Deficiency Treatment Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Factor IX Deficiency Treatment Revenue Market Share by Regions (2015-2020)
Table 39. North America Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
Table 40. North America Factor IX Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Table 41. Europe Factor IX Deficiency Treatment Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Factor IX Deficiency Treatment Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
Table 44. South America Factor IX Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Factor IX Deficiency Treatment Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Factor IX Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Table 47. Global Factor IX Deficiency Treatment Revenue (Million USD) by Type (2015-2020)
Table 48. Global Factor IX Deficiency Treatment Revenue Share by Type (2015-2020)
Table 49. Global Factor IX Deficiency Treatment Revenue Forecast by Type (2021-2025)
Table 50. Global Factor IX Deficiency Treatment Revenue by Application (2015-2020)
Table 51. Global Factor IX Deficiency Treatment Revenue Share by Application (2015-2020)
Table 52. Global Factor IX Deficiency Treatment Revenue Forecast by Application (2021-2025)
Table 53. Global Factor IX Deficiency Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Factor IX Deficiency Treatment Picture
Figure 2. Global Factor IX Deficiency Treatment Revenue Market Share by Type in 2019
Figure 3. Hemophilia B Picture
Figure 4. Hemophilia B Inhibitors Picture
Figure 5. Factor IX Deficiency Treatment Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Other Picture
Figure 9. Global Factor IX Deficiency Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Factor IX Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Factor IX Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Factor IX Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Factor IX Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Factor IX Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Factor IX Deficiency Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Factor IX Deficiency Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Factor IX Deficiency Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Factor IX Deficiency Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Factor IX Deficiency Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Factor IX Deficiency Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Factor IX Deficiency Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Factor IX Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Factor IX Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Factor IX Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Factor IX Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Factor IX Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Factor IX Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 42. China Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Factor IX Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Factor IX Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Factor IX Deficiency Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Factor IX Deficiency Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Factor IX Deficiency Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Factor IX Deficiency Treatment Revenue Share by Type in 2019
Figure 59. Global Factor IX Deficiency Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Hemophilia B Revenue Growth Rate (2015-2020)
Figure 61. Global Hemophilia B Inhibitors Revenue Growth Rate (2015-2020)
Figure 62. Global Factor IX Deficiency Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Factor IX Deficiency Treatment Revenue Share by Application in 2019
Figure 64. Global Factor IX Deficiency Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Factor IX Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Factor IX Deficiency Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Factor IX Deficiency Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
第VIII因子欠乏症治療の世界市場 2020年 Market Overview The global Factor VIII Deficiency Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Factor VIII …- ヒト凝固因子VIIの世界市場 2020年 Market Overview The Human Coagulation Factor VII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 間質細胞由来因子1の世界市場 2020年 Market Overview The global Stromal Cell Derived Factor 1 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stromal Cell De…
- 力率改善（PFC）装置の世界市場 2020年 Market Overview The Power Factor Correction Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 線維芽細胞成長因子2の世界市場 2020年 Market Overview The global Fibroblast Growth Factor 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fibroblast Growth …